Search

everythinglearnresearchcommunity

for

Search:↓

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

New compounds may help treat prostate cancer by reducing cell growth.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

CT scans can find serious prostate cancer even when PSA levels are low.

PSA can help diagnose high androgen levels in women.

Some common medications can lower PSA levels in 45-year-old German men.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Long-term diabetes is linked to lower prostate cancer risk.

Higher serum androgens contribute to male pattern baldness.